Variation in apparent serum digitalis-like factor levels with different digoxin antibodies. The "immunochemical fingerprint".
Increased levels of a circulating digoxin-like factor (DLF) occur in a number of physiologic states in which sodium homeostasis is altered, and may contribute to the pathogenesis of hypertension. We exploited the different affinities for DLF of seven antisera directed at digoxin to develop an immunochemical profile, and then employed this index to address two questions: does the same DLF species exist in several conditions associated with increased DLF levels, including pregnancy, renal failure, hepatic failure, and neonatal cord blood? Will this approach prove useful in assessing candidates proposed to be DLF? An identical profile was identified in serum from pregnant women and patients with renal or hepatic failure, and a highly significant correlation existed between DLF levels measured with antisera of high and intermediate affinity in 42 subjects with increased levels (r = 0.93; P less than .001). In patients with renal failure, when endogenous DLF levels were too low to assess the profile, concentration of the serum resulted in measurable DLF levels that had an identical profile. The profile was somewhat altered in umbilical cord blood, perhaps reflecting an influence of increased steroid hormone levels. Among agents suggested as candidates for DLF, neither lysophosphatidylcholine nor ouabain showed a profile resembling DLF. Progesterone, 17-OH-progesterone, and bufalin, on the other hand, did show substantial similarity, perhaps providing a clue to the structure of DLF. The normal plasma levels of progesterone and 17-OH-progesterone are 100- to 1000-fold too low to be candidates for DLF and bufalin was sufficiently dissimilar not to be a candidate. DLF in at least three different patient populations probably represents identical chemical species.(ABSTRACT TRUNCATED AT 250 WORDS)
Naomi
S
S
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Graves
S
S
Lazarus
M
M
Williams
G H
GH
Hollenberg
N K
NK
D000906:Antibodies / Q000276:immunology / Q000502:physiology*; D000915:Antibody Affinity / Q000276:immunology; D000918:Antibody Specificity / Q000276:immunology; D001798:Blood Proteins / Q000032:analysis* / Q000276:immunology; D002018:Bufanolides / Q000097:blood; D002298:Cardenolides; D004077:Digoxin / Q000097:blood / Q000276:immunology*; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000276:immunology; D008107:Liver Diseases / Q000097:blood / Q000276:immunology; D011247:Pregnancy / Q000097:blood / Q000276:immunology; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay; D012503:Saponins
D000906:Antibodies; D001798:Blood Proteins; D002018:Bufanolides; D002298:Cardenolides; D012503:Saponins; C034504:digoxin-like factors; D011374:Progesterone; D004077:Digoxin; C022777:bufalin